Dr. David Y Gin, RIP

From the New York Times, 25 March 2011:

GIN–David Y. The staff of Memorial Sloan-Kettering Cancer Center note with sadness the untimely death of our esteemed colleague David Y. Gin, a brilliant and talented chemist who joined the Sloan-Kettering Institute’s Molecular Pharmacology and Chemistry Program in 2006.

Dr. Gin was working at the nexus of synthetic chemistry, clinical trials, and research to develop new, safer, and more-potent immunological and therapeutic agents for cancer and infectious diseases. He was a gentle, kind, good-humored, and remarkable human being who will be sorely missed.

We extend our deepest condolences to his wife, Mary; his children, Duncan and Laura; and his entire family. David A. Scheinberg, MD, PhD Chair, Molecular Pharmacology and Chemistry Program Thomas J. Kelly, MD, PhD Director, Sloan-Kettering Institute Craig B. Thompson, MD President & CEO, Memorial Sloan-Kettering Cancer Center

###